News from the healthcare data industry
COTA joins consortium of biopharma companies, data sharing platforms, academic institutions, and service and technology partners to usher in the next generation of data-driven healthcare January 31, 2023 08:11 AM...
Miruna Sasu, CEO of RWE company COTA, explained that studies have shown meaningful improvements in efficiency if RWE is used in drug development and that translates into real savings. However,...
New partnership focused on bringing clarity to unstructured oncology data through the latest advancements in machine learning and natural language processing NEW YORK, Nov. 14, 2022 /PRNewswire/ — COTA, Inc. , an oncology real-world data...
Financing will be used to accelerate and further diversify COTA’s oncology real-world data products and services NEW YORK, Oct. 25, 2022 /PRNewswire/ — COTA, Inc., an oncology real-world data and analytics company, announced...
Miruna Sasu, PhD, MBA, president and CEO of COTA Healthcare, discusses 3 ways in which the FDA can provide, and has provided, assistance on the capture of real-word data (RWD)...
Miruna Sasu, PhD, MBA, president and CEO of COTA Healthcare, discusses the medicines discovery process and how real-world data can be used to evaluate patient and tumor response to treatment...
May 15, 2022Mary Caffrey, Maggie L. Shaw Miruna Sasu, PhD, MBA, president and CEO of COTA Healthcare, delves into how real-world data and evidence generation have changed, both within the past...
May 2, 2022C.K. Wang, MD By integrating real-world data more deeply into the process of clinical research, life sciences stakeholders can open up new possibilities for therapeutic development and the...
April 20, 2022 From exposing disparities in care to guiding better patient outcomes to helping reign in the costs of care, the use of real-world data (RWD) in oncology can...
In an interview with Targeted Oncology, C.K. Wang, MD, discussed the importance of real-world data in oncology, the mission of COTA, and research the company has been a part of....